Please check your internet connection and try again.
```markdown
# Tus%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd
## Overview
Tus%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520qd is a combination medication containing two expectorants, guaifenesin and hydrocodone. Guaifenesin thins and loosens mucus, while hydrocodone is an opioid antitussive that suppresses the cough reflex.
## Primary Indications
* Symptomatic relief of cough and to promote the removal of mucus.
## Adult Dosing
* **Typical dose:** 5 mL to 10 mL orally every 4 to 6 hours as needed.
* **Maximum dose:** Not to exceed 6 doses in a 24-hour period. Specific maximum daily dose is not clearly established and depends on individual patient response and tolerability.
## Pediatric Dosing
* Dosing in pediatric patients is not well-established and should be determined by a healthcare provider based on age, weight, and clinical condition. Caution is advised due to the potential for respiratory depression with hydrocodone.
## Dose Adjustments
* **Renal Impairment:** Use with caution. No specific dose adjustment is routinely recommended, but monitoring for adverse effects is crucial.
* **Hepatic Impairment:** Use with caution. No specific dose adjustment is routinely recommended, but monitoring for adverse effects is crucial.
## Contraindications
* Hypersensitivity to hydrocodone or guaifenesin.
* Severe respiratory depression.
* Acute or severe asthma or other obstructive airway disease.
* Gastrointestinal obstruction or ileus.
* Use with MAO inhibitors or within 14 days of stopping MAO inhibitors.
## Adverse Effects
* **Common:** Drowsiness, dizziness, sedation, nausea, vomiting, constipation, dry mouth, pruritus.
* **Serious:** Respiratory depression, severe hypotension, CNS depression, dependence (physical and psychological), abuse potential, neonatal withdrawal syndrome if used during pregnancy.
## Key Drug Interactions
* **CNS Depressants (e.g., alcohol, benzodiazepines, other opioids):** Increased risk of profound sedation, respiratory depression, coma, and death.
* **MAO Inhibitors:** May potentiate the effects of hydrocodone, leading to potentially fatal reactions.
* **Anticholinergics:** Increased risk of urinary retention and severe constipation.
* **CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir):** May increase hydrocodone plasma concentrations, leading to increased adverse effects.
## Monitoring
* Respiratory rate and depth.
* Level of sedation and consciousness.
* Bowel function (for constipation).
* Signs of abuse or dependence.
## Clinical Pearls
* Hydrocodone component carries a risk of abuse, dependence, and diversion.
* Advise patients to avoid driving or operating heavy machinery until they know how this medication affects them.
* Encourage increased fluid intake and cough/deep breathing exercises to aid mucus clearance.
* Consider non-opioid alternatives for cough suppression if possible, especially for chronic conditions or in patients with a history of substance abuse.
***
*Disclaimer: This information is intended for clinical use and is not a substitute for professional medical advice. Always verify current prescribing information and consult with a qualified healthcare provider before making any decisions related to patient care.*
```
